Stay updated on BMS-986205 Immuno-Therapy Combo Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 Immuno-Therapy Combo Clinical Trial page.

Latest updates to the BMS-986205 Immuno-Therapy Combo Clinical Trial page
- Check2 days agoChange DetectedThe page now presents the completed study record for the BMS-986205 combination-therapy trial, including its outcomes, eligibility criteria, and study locations, instead of an error page.SummaryDifference85%

- Check9 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 on the 403 Forbidden study-record page.SummaryDifference0.2%

- Check16 days agoChange DetectedA sitewide banner announces an NIH transition and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference1%

- Check23 days agoChange DetectedThe footer’s site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check30 days agoChange DetectedThe site's footer revision identifier changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the previously visible trial details and navigation. The page shows a minimal HTML header and a footer with a revision notice (Revision: v3.7.0), indicating restricted access and a site revision.SummaryDifference20%

Stay in the know with updates to BMS-986205 Immuno-Therapy Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 Immuno-Therapy Combo Clinical Trial page.